MOVABEY
LIVE

Serial Number

79379883

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MOVABEY Trademark

Serial Number: 79379883 • Registration: 7292531

MOVABEY is a trademark filed by NOVARTIS AG on December 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 16, 2022

Registration Date

January 30, 2024

Published for Opposition

November 14, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 20, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 27, 2025 OPNR
NOTIFICATION PROCESSED BY IB
Apr 1, 2024 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 4, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 4, 2024 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 29, 2024 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 1, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 1, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 16, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 16, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 16, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Oct 14, 2023 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2023 CNSA
ASSIGNED TO EXAMINER
Oct 10, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 2, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 28, 2023 SDRC